Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

10.36
Delayed Data
As of Jul 21
 -0.04 / -0.38%
Today’s Change
8.75
Today|||52-Week Range
15.45
-0.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-43.0M-83.6M40.4M-41.2M
 
 
 
 
 
Depreciation3.1M13.9M13.1M14.4M
 
 
 
 
 
Total Other Cash Flow30.2M43.3M33.7M70.9M
 
 
 
 
 
Funds From Operations-21.0M-29.1M88.6M40.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-280.2K-18.7M4.8M21.3M
 
 
 
 
 
Net Cash Flow - Operating Activities-20.7M-10.5M83.8M18.8M
 
 
 
 
 
 
InvestingIncrease In Investments-1.1M-67.2M-50.3M-107.3M
 
 
 
 
 
Decrease In Investments7.2M13.5M20.4M71.3M
 
 
 
 
 
Capital Expenditures-1.0M-1.7M-1.6M-1.2M
 
 
 
 
 
Fixed Asset Disposal1.0M13.0M0.00626.2K
 
 
 
 
Net Cash Flow Investing6.0M-42.4M-31.6M-36.5M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings19.3M0.000.000.00
 
 
Long Term Debt Reduction-552.4K-34.4M-9.0M-1.5M
 
 
 
 
 
Net Proceeds Stock Sale400.3K130.2M7.0M438.7K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.002.8M0.00
 
 
Other Uses - Financing907.6K1.3M24.4M6.9M
 
 
 
 
 
Net Cash Flow - Financing18.3M94.5M-23.6M-7.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash252.2K-9.0M-3.5M-165.5K
 
 
 
 
 
 
Net Change In Cash3.6M41.7M28.7M-25.6M